CO6382120A2 - Compuestos ciclopropilo - Google Patents

Compuestos ciclopropilo

Info

Publication number
CO6382120A2
CO6382120A2 CO11079303A CO11079303A CO6382120A2 CO 6382120 A2 CO6382120 A2 CO 6382120A2 CO 11079303 A CO11079303 A CO 11079303A CO 11079303 A CO11079303 A CO 11079303A CO 6382120 A2 CO6382120 A2 CO 6382120A2
Authority
CO
Colombia
Prior art keywords
cyclopropyl compounds
pharmaceutically acceptable
cyclopropyl
compounds
diabetes
Prior art date
Application number
CO11079303A
Other languages
English (en)
Inventor
Melendo Ana Belen Bueno
Chicharro Francisco Javier Agejas
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO6382120A2 publication Critical patent/CO6382120A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un compuesto de la fórmula:y composiciones farmacéuticas, o una sal farmacéuticamente aceptable del mismo, y un diluyente o portador farmacéuticamente aceptable, para el tratamiento de diabetes.
CO11079303A 2008-12-19 2011-06-23 Compuestos ciclopropilo CO6382120A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08380341 2008-12-19
US15378109P 2009-02-19 2009-02-19

Publications (1)

Publication Number Publication Date
CO6382120A2 true CO6382120A2 (es) 2012-02-15

Family

ID=40545955

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11079303A CO6382120A2 (es) 2008-12-19 2011-06-23 Compuestos ciclopropilo

Country Status (34)

Country Link
US (1) US8063079B2 (es)
EP (1) EP2379517B1 (es)
JP (1) JP5497064B2 (es)
KR (1) KR101290437B1 (es)
CN (1) CN102256952B (es)
AR (1) AR074470A1 (es)
AU (1) AU2009335931B2 (es)
BR (1) BRPI0923183B1 (es)
CA (1) CA2746746C (es)
CO (1) CO6382120A2 (es)
CR (1) CR20110342A (es)
DK (1) DK2379517T3 (es)
DO (1) DOP2011000197A (es)
EA (1) EA019055B1 (es)
EC (1) ECSP11011150A (es)
ES (1) ES2435242T3 (es)
HR (1) HRP20130983T1 (es)
IL (1) IL213210A (es)
JO (1) JO2979B1 (es)
MA (1) MA32902B1 (es)
MX (1) MX2011006434A (es)
MY (1) MY180567A (es)
NZ (1) NZ592930A (es)
PA (1) PA8851901A1 (es)
PE (1) PE20120339A1 (es)
PL (1) PL2379517T3 (es)
PT (1) PT2379517E (es)
SG (1) SG172256A1 (es)
SI (1) SI2379517T1 (es)
TN (1) TN2011000294A1 (es)
TW (1) TWI395748B (es)
UA (1) UA104742C2 (es)
WO (1) WO2010080333A1 (es)
ZA (1) ZA201103944B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102959076B (zh) 2010-03-31 2015-09-16 斯克里普斯研究所 重编程细胞
CA2931056C (en) 2013-11-22 2023-02-28 The University Of Tokyo Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176915C (zh) 2000-05-03 2004-11-24 霍夫曼-拉罗奇有限公司 炔基苯基芳香杂环的菊糖激酶激活剂
JP3839723B2 (ja) 2000-05-08 2006-11-01 エフ．ホフマン−ラ ロシュ アーゲー 置換フェニルアセトアミドおよびグルコキナーゼ活性化剤としてのその使用
WO2001085707A1 (en) 2000-05-08 2001-11-15 F. Hoffmann-La Roche Ag Para-amine substituted phenylamide glucokinase activators
US7132425B2 (en) * 2002-12-12 2006-11-07 Hoffmann-La Roche Inc. 5-substituted-six-membered heteroaromatic glucokinase activators
WO2004063179A1 (en) 2003-01-06 2004-07-29 Eli Lilly And Company Substituted arylcyclopropylacetamides as glucokinase activators
PL378117A1 (pl) 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
WO2004072066A1 (en) 2003-02-11 2004-08-26 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
US7432287B2 (en) * 2003-02-26 2008-10-07 Banyu Pharmeceutical Co., Ltd. Heteroarylcarbamoylbenzene derivative
US20080242869A1 (en) 2004-04-21 2008-10-02 Matthew Fyfe Tri(Cyclo) Substituted Amide Compounds
BRPI0514147A (pt) 2004-08-12 2008-05-27 Prosidion Ltd composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento profilático ou terapêutico de uma condição onde a ativação de gk é desejável, de tratamento profilático ou terapêutico da hiperglicemia ou diabete e de prevenção da diabete em um ser humano que demosntra hiperglicemia pré-diabética ou toleráncia à glicose prejudicada, e, processo para a preparação do composto
CN101137631A (zh) * 2004-12-03 2008-03-05 转化技术制药公司 杂芳族葡糖激酶激活剂
MX2007016393A (es) 2005-07-01 2008-03-10 Novartis Ag Combinacion de un inhibidor de renina y un potenciador de la secrecion de insulina o un sensibilizante a la insulina.
US7514439B2 (en) 2005-07-11 2009-04-07 Mitsubishi Tanabe Pharma Corporation Oxime derivative and preparations thereof
WO2007017649A1 (en) * 2005-08-09 2007-02-15 Astrazeneca Ab Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
BRPI0618062A2 (pt) 2005-11-03 2011-08-16 Prosidion Ltd composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
WO2007051846A1 (en) 2005-11-03 2007-05-10 Prosidion Ltd Tricyclo substituted amides
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
KR20090025358A (ko) * 2006-07-24 2009-03-10 에프. 호프만-라 로슈 아게 글루코키나제 활성화제로서의 피라졸
EP2105435A4 (en) * 2007-01-10 2011-06-15 Mitsubishi Tanabe Pharma Corp Hydrazone derivatives
SI2275414T1 (sl) 2008-04-28 2015-10-30 Kyorin Pharmaceutical Co., Ltd., Ciklopentilakrilamidni derivat

Also Published As

Publication number Publication date
EA201170845A1 (ru) 2011-12-30
CR20110342A (es) 2011-09-14
JP5497064B2 (ja) 2014-05-21
TN2011000294A1 (en) 2012-12-17
DK2379517T3 (da) 2013-09-30
CN102256952B (zh) 2013-12-11
EP2379517A1 (en) 2011-10-26
US8063079B2 (en) 2011-11-22
IL213210A0 (en) 2011-07-31
CA2746746C (en) 2013-09-24
ES2435242T3 (es) 2013-12-17
PA8851901A1 (es) 2010-07-27
PT2379517E (pt) 2013-11-21
JO2979B1 (en) 2016-03-15
AU2009335931B2 (en) 2012-05-31
BRPI0923183A2 (pt) 2016-02-16
SI2379517T1 (sl) 2013-10-30
TWI395748B (zh) 2013-05-11
NZ592930A (en) 2013-01-25
EA019055B1 (ru) 2013-12-30
HRP20130983T1 (hr) 2013-11-22
US20100160395A1 (en) 2010-06-24
MX2011006434A (es) 2011-07-19
IL213210A (en) 2015-03-31
MY180567A (en) 2020-12-02
WO2010080333A1 (en) 2010-07-15
PL2379517T3 (pl) 2014-01-31
SG172256A1 (en) 2011-07-28
KR20110086751A (ko) 2011-07-29
MA32902B1 (fr) 2011-12-01
BRPI0923183B1 (pt) 2019-03-19
JP2012512874A (ja) 2012-06-07
UA104742C2 (uk) 2014-03-11
KR101290437B1 (ko) 2013-07-29
ECSP11011150A (es) 2011-07-29
AU2009335931A1 (en) 2011-07-07
CN102256952A (zh) 2011-11-23
EP2379517B1 (en) 2013-08-28
CA2746746A1 (en) 2010-07-15
TW201029999A (en) 2010-08-16
DOP2011000197A (es) 2011-09-15
PE20120339A1 (es) 2012-04-16
ZA201103944B (en) 2012-11-28
AR074470A1 (es) 2011-01-19
BRPI0923183A8 (pt) 2017-09-12

Similar Documents

Publication Publication Date Title
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
CR20120296A (es) Nuevos compuestos de espiropiperidina
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
EA201170872A1 (ru) Ингибиторы протеинкиназы
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
MY153915A (en) Organic compounds
CL2007003758A1 (es) Compuestos derivados de aminopirimidina, inhibidores de plk1; composicion farmaceutica, util para el tratamiento de cancer.
AR087451A1 (es) Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
EA201490161A1 (ru) Соединения - ингибиторы сигналинга, опосредуемого рецептором notch
TN2013000413A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
UY32424A (es) Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales
UA110207C2 (en) Pharmaceutical pill that contains 1- (-d- hlyukopiranozyl) -4-methyl -3- [5- (4-fluorophenyl) -2 inhibitors tiyenilmetyl benzol natriydependent transporter of glucose (nzph)
CR20110264A (es) Pirazolilaminopiridinas como inhibidores de fak
CR20120084A (es) Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
PE20141993A1 (es) Compuestos de benzotiazolona
CO6382120A2 (es) Compuestos ciclopropilo
CL2013002584A1 (es) Compuestos derivados de 2-(2-metilpropanoil)pirazolidin-3-carboxamida, inhibidores de la peptido desformilasa (pdf); composición farmaceutica, utiles en el tratamiento de una infeccion bacteriana.
AR083780A1 (es) Composicion farmaceutica para tratar infecciones del hcv
WO2013074905A3 (en) Compounds, compositions, pharmaceutical compositions, and methods of use
CL2011000120A1 (es) Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas.
EA201300160A1 (ru) 2,3,5-тризамещенные тиофены и их применение
CO2019005512A2 (es) Fármaco terapéutico o fármaco profiláctico para la nefropatía diabética
EP2570408A4 (en) HEXACETIDE COMPOUND AND MEDICINAL USE THEREOF

Legal Events

Date Code Title Description
FG Application granted